# Pepex Biomedical, Inc. — Form D

Pepex Biomedical, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-27. The offering totals $3.0M, of which $202K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-04-27
- Form: D
- Accession: 0001547860-12-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $202K
- Remaining: $2.8M
- Minimum investment: $202K
- Investors: 1
- Date of first sale: 2012-04-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-177341

## Issuer

- Name: Pepex Biomedical, Inc.
- CIK: 0001547860
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 4041 FOREST PARK AVENUE, ST. LOUIS, MO, 63108
- Phone: 314-633-5053

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| STEVE COLLINS | Director | SALT LAKE CITY, UT |
| Joseph Driver | Director | St. Louis, MO |
| Nathan Long | Director | St. Louis, MO |
| Ira Potter | Director | St. Louis, MO |
| James Say | Director | St. Louis, MO |
| STEVE COLLINS | Executive Officer | SALT LAKE CITY, UT |
| Joseph Driver | Executive Officer | St. Louis, MO |
| James Say | Executive Officer | St. Louis, MO |
| STEVE COLLINS | Promoter | SALT LAKE CITY, UT |
| Joseph Driver | Promoter | St. Louis, MO |

## More

- [CIK 1547860 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1547860&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001547860-12-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.